Clinical Trial TitleThe FRESH study: A study evaluating the safety, tolerability, and efficacy of an investigational drug in patients with severe alcohol-associated hepatitis
National Clinical Trial Number:NCT05639543
Clinical Trial Protocol Description:
Study for an investigational drug vs placebo for patients who are in the hospital with severe alcoholic hepatitis. Patients must be willing to travel to Rush's downtown campus for 7-8 follow-up visits once discharged from the hospital.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Have a history of excess alcohol use for greater than or equal to 6 months.
- Have become jaundiced (yellowing of skin) within 8 weeks of hospital admission.
You will be excluded from the study if any of the following criteria apply to you:
- Have taken systemic corticosteroids or products containing obeticholic acid in the past 30 days .
- Have been diagnosed with malignancy within the 2 years prior to Screening.
This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.